Global Information
회사소개 | 문의 | 비교리스트

세계의 전기치료/생체전기요법 시장

Electroceuticals / Bioelectric Medicine

리서치사 Global Industry Analysts, Inc.
발행일 2022년 01월 상품 코드 906642
페이지 정보 영문 185 Pages
가격
US $ 4,950 ₩ 5,962,000 PDF (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 14,850 ₩ 17,886,000 PDF (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 전기치료/생체전기요법 시장 Electroceuticals / Bioelectric Medicine
발행일 : 2022년 01월 페이지 정보 : 영문 185 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 전기치료/생체전기요법(Electroceuticals/Bioelectric Medicine) 시장에 대해 조사 분석했으며, 시장 정의와 개요, 성장에 대한 각종 영향요인 분석, 경쟁사와 시장 점유율, 세계 및 지역·주요 국가별 시장 규모 추정과 예측, 각종 세분화별 내역, 주요 기업 개요 등을 정리했습니다.

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
    • 세계의 경쟁사 시장 점유율
    • 세계의 경쟁사 시장 점유율 시나리오
    • 세계의 경쟁사 시장 점유율 : 부문별
    • 이식형 : 세계의 경쟁사 시장 점유율 포지셔닝
    • 비침습형 : 주요 기업의 시장 점유율 내역
  • 주요 기업에 대한 포커스
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 지역 시장 분석
  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타(ROW)

제4장 경쟁

  • ABBOTT LABORATORIES
  • BIOTRONIK SE & CO. KG
  • BOSTON SCIENTIFIC CORPORATION
  • COCHLEAR
  • ELECTROCORE
  • LIVANOVA PLC
  • MEDTRONIC PLC
  • NEVRO CORP.
  • SECOND SIGHT MEDICAL PRODUCTS
  • SONOVA HOLDING AG

제5장 관련 조사

KSM 19.09.18

Abstract:

Global Electroceuticals / Bioelectric Medicine Market to Reach US$20.8 Billion by the Year 2026

Electroceuticals have a lot of potential to become the principal method of medical treatment. The relatively new area of Bioelectric medicine/Electroceutical devices has provided a new approach to treatment of chronic illnesses. As the treatment is through electrical impulses rather than drugs, there is less chance of major side effects and further, the therapy also results in the body producing endorphins which gives relief from pain. This new form of treatment through devices can address resynchronization, defibrillation and pacemaker application normally used in the field of cardiology. The technology also has its use in treating heart failure, atrial fibrillation, diseases related to the coronary artery, myocarditis, resistant hypertension, ventricular as well as atrial tachyarrhythmias, pulseless electrical activity and refractory angina. The heightened pace of research in the area of bioelectric medicine is also likely to boost future business. Companies are exploring on non-surgical methods of implantation and improved features of electrode technologies for making the embedding process of the biomedicines possible through the skin. Such non-invasive electroceutical devices also show promising future due to the comfort factor attached to them for patients who do not have to incur surgical costs and inconvenience of post-surgery recovery.

Amid the COVID-19 crisis, the global market for Electroceuticals / Bioelectric Medicine estimated at US$15 Billion in the year 2020, is projected to reach a revised size of US$20.8 Billion by 2026, growing at a CAGR of 5.6% over the analysis period. Cardiac Pacemakers & ICDs, one of the segments analyzed in the report, is projected to grow at a 6.5% CAGR to reach US$13.5 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Cochlear Implants segment is readjusted to a revised 4.6% CAGR for the next 7-year period. This segment currently accounts for a 14.8% share of the global Electroceuticals / Bioelectric Medicine market. Cardiac diseases have increased globally, fueling the market growth of the cardiac pacemaker. A cardiac pacemaker when placed in the chest uses electrical pulses to control arrhythmia or abnormal heart rhythm of patients. Cochlear implant is one of the most common electroceutical for substituting damaged ear part and providing hearing ability.

The U.S. Market is Estimated at $6.9 Billion in 2021, While China is Forecast to Reach $1.7 Billion by 2026

The Electroceuticals / Bioelectric Medicine market in the U.S. is estimated at US$6.9 Billion in the year 2021. The country currently accounts for a 44.6% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$1.7 Billion in the year 2026 trailing a CAGR of 6.7% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR while Rest of European market (as defined in the study) will reach US$1.8 Billion by the end of the analysis period. North America, with its well-developed healthcare infrastructure, is widespread adopter of new technologies, thus providing favorable growth outlook for electroceuticals/ bioelectric medicine technology. The growing number of people suffering from a range of chronic medical conditions like cardiovascular disease, neurological ailments, cancer, arrhythmia, and hearing loss are propelling growth in the region. The presence of leading medical device makers including Boston Scientific Corporation, Medtronic and BIOTRONIK in the region augurs well for the market. In Europe, the substantial infrastructure for healthcare, high demand for innovative medical solutions and the presence of several healthcare majors in Germany, the UK, Switzerland, and France, are presenting robust growth opportunities.

Spinal Cord Stimulators Segment to Reach $2.9 Billion by 2026

A spinal cord stimulator is an implanted device that sends low levels of electricity directly into the spinal cord. Spinal cord stimulators consist of electrodes, or leads, placed in the epidural space around the spinal cord. The electrodes are connected to and powered by a pulse generator or batteries. In the global Spinal Cord Stimulators segment, USA, Canada, Japan, China and Europe will drive the 4.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.9 Billion in the year 2020 will reach a projected size of US$2.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$205.4 Million by the year 2026.

Select Competitors (Total 50 Featured) -

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • electroCore, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • Nevro Corp.
  • Second Sight Medical Products, Inc.
  • Sonova Holding AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of COVID-19 Pandemic and Looming Global Recession
    • 2020: A Year of Disruption & Transformation
    • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021?
    • EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • COVID-19 Impact on the Electroceuticals/Bioelectric Medicine Market
    • Researchers Demonstrate Role of Electroceutical Fabric in Eradicating Coronaviruses
    • An Introduction to Electroceuticals/Bioelectric Medicine
    • Using Electrical Stimulation in Nerves: Historical Perspective
    • Types of Electroceutical Devices
    • Major Applications of Electroceuticals/Bioelectric Medicine
    • Global Market Prospects & Outlook
    • Implantable Electroceutical Devices: The Leading Category
    • Cardiac Pacemakers & Implantable Cardioverter Defibrillators Segment Lead the Global Market
    • Developed Regions Lead, Developing Economies to Spearhead Growth
    • Competition
    • EXHIBIT 2: Global DBS Market Share Breakdown of Revenues by Leading Players: 2020E
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Electroceutical/Biomedical Medicine Emerges to Overcome Drawbacks of Traditional Treatments
    • Faster Healing: A Key Benefit Fueling Growth in Electroceuticals Market
    • Ineffectiveness of Drug Therapy and Issues with Side Effects Present Opportunities for Electroceuticals Market
    • Disease-specific Electroceuticals to Drive Future Gains
    • Aging Global Population Raises Risk of Neurological & Cardiovascular Diseases, Fueling Market Outlook
    • EXHIBIT 3: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • EXHIBIT 4: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Growing Prevalence of Cardiovascular Diseases and Need for Effective Treatments Supports Market Growth
    • EXHIBIT 5: Global Annual Medical Cost of CVD in US$ Billion: 2010, 2015, 2020, 2025 and 2030
    • EXHIBIT 6: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • EXHIBIT 7: Leading Causes of Death Worldwide: 2019
    • Cardiac Pacemaker: A Solution for Cardiac Arrythmias
    • Transcatheter Cardiac Pacemakers: Benefits Fuel Market Growth
    • Technological Advancements to Transform Cardiac Pacemaker Devices Marketplace
    • Rising Incidence of Neurological Disorders and Need for Novel Therapies to Spur Market Growth
    • EXHIBIT 8: Annual Incidence of Adult-Onset Neurologic Disorders in the US
    • Bioelectronic Medicine Emerges as a Vital Therapy for Targeted Neuromodulation
    • Deep Brain Stimulators: Useful in Treatment of Neurodegenerative Diseases
    • EXHIBIT 9: Global Alzheimer's Prevalence by Age Group
    • EXHIBIT 10: Diagnosed Prevalence Cases of Parkinson's Disease in Select Countries
    • Select Available Deep Brain Stimulation Devices Available in the Market
    • Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve Stimulation Devices
    • EXHIBIT 11: Epilepsy Incidence Worldwide by Type: Percentage Breakdown for Idiopathic and Symptomatic Epilepsy by Type (2020)
    • EXHIBIT 12: Symptomatic Epilepsy Incidence: Percentage of Incidence by Type for 2020
    • Developments in Vagal Nerve Stimulation (VNS) Devices
    • Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
    • TENS (Transcutaneous electrical nerve stimulation devices) Market Witnesses Rapid Growth
    • Biodegradable Devices For Nerve Recovery
    • Bioelectric Medicine: A Potential Treatment Approach for Crohn's Disease
    • Growing Prevalence of Hearing Loss Boosts Opportunities in the Cochlear Implants Market
    • EXHIBIT 13: Global Prevalence (%) by Severity of Hearing Loss
    • Vendors Focus on Innovations in Cochlear Implants
    • Developing Economies to Boost Long-term Prospects
    • Electroceutical Acupuncture: Emerging Pain Therapy
    • Neuropuncture - The Electroceutical Technology to Treat Pain & Injury
    • Bioelectronics Technology Fuels Advances in Next-Generation of Device Therapeutics
    • Market Benefits from the Significant Advantages of Bioelectronics
    • Overcoming the Challenges
    • Increasing Research Activity in Bioelectric Medicine Drives Market Opportunities
    • Market Poised to Benefit from the Development of New Bioelectronic Devices
    • Technological Advancements to Boost Growth Prospects
    • Rise in Healthcare Expenditure to Drive Growth
    • EXHIBIT 14: World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 & 2023
    • EXHIBIT 15: Elderly Healthcare Expenditure as a % of GDP in the US, Europe and Japan for 1970, 2010 and 2050
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Electroceuticals / Bioelectric Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Electroceuticals / Bioelectric Medicine by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
    • TABLE 4: World Current & Future Analysis for Cardiac Pacemakers & ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Cardiac Pacemakers & ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Cardiac Pacemakers & ICDs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 7: World Current & Future Analysis for Cochlear Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Cochlear Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Cochlear Implants by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 10: World Current & Future Analysis for Spinal Cord Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Spinal Cord Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Spinal Cord Stimulators by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 13: World Current & Future Analysis for Deep Brain Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Deep Brain Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Deep Brain Stimulators by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 16: World Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 19: World Current & Future Analysis for Hospitals, Clinics & ASCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Hospitals, Clinics & ASCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals, Clinics & ASCs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 22: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 25: USA Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: USA 15-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2012, 2021 & 2027
    • TABLE 28: USA Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2012, 2021 & 2027
  • CANADA
    • TABLE 31: Canada Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Canada Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: Canada 15-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2012, 2021 & 2027
    • TABLE 34: Canada Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Canada Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Canada 15-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2012, 2021 & 2027
  • JAPAN
    • TABLE 37: Japan Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Japan Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: Japan 15-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2012, 2021 & 2027
    • TABLE 40: Japan Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Japan Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: Japan 15-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2012, 2021 & 2027
  • CHINA
    • TABLE 43: China Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: China Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: China 15-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2012, 2021 & 2027
    • TABLE 46: China Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: China Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: China 15-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2012, 2021 & 2027
  • EUROPE
    • TABLE 49: Europe Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe Historic Review for Electroceuticals / Bioelectric Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: Europe 15-Year Perspective for Electroceuticals / Bioelectric Medicine by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
    • TABLE 52: Europe Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2012, 2021 & 2027
    • TABLE 55: Europe Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Europe Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: Europe 15-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2012, 2021 & 2027
  • FRANCE
    • TABLE 58: France Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: France Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: France 15-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2012, 2021 & 2027
    • TABLE 61: France Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: France Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: France 15-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2012, 2021 & 2027
  • GERMANY
    • TABLE 64: Germany Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Germany Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: Germany 15-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2012, 2021 & 2027
    • TABLE 67: Germany Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Germany Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: Germany 15-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2012, 2021 & 2027
  • ITALY
    • TABLE 70: Italy Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Italy Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: Italy 15-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2012, 2021 & 2027
    • TABLE 73: Italy Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Italy Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: Italy 15-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2012, 2021 & 2027
  • UNITED KINGDOM
    • TABLE 76: UK Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: UK Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: UK 15-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2012, 2021 & 2027
    • TABLE 79: UK Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: UK Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: UK 15-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Rest of Europe Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: Rest of Europe 15-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2012, 2021 & 2027
    • TABLE 85: Rest of Europe Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Rest of Europe Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: Rest of Europe 15-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2012, 2021 & 2027
  • ASIA-PACIFIC
    • TABLE 88: Asia-Pacific Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Asia-Pacific Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: Asia-Pacific 15-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2012, 2021 & 2027
    • TABLE 91: Asia-Pacific Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Asia-Pacific Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: Asia-Pacific 15-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF WORLD
    • TABLE 94: Rest of World Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Rest of World Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 96: Rest of World 15-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2012, 2021 & 2027
    • TABLE 97: Rest of World Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Rest of World Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 99: Rest of World 15-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2012, 2021 & 2027

IV. COMPETITION

  • Total Companies Profiled: 50
Back to Top
전화 문의
F A Q